What Do the 2027 ACA Marketing Rules Require Starting July 20, 2026?
The 2027 Notice of Benefit and Payment Parameters becomes effective July 20, 2026. Agents, brokers, and web-brokers covered by the rule must provide accurate information, avoid misleading or coercive marketing, oversee marketing produced on their behalf, and be able to provide marketing materials to the Department of Health and Human Services when requested.
Strategic Advisor, Insurance Growth, Medicare Distribution, and Compliance
| Question | Answer |
|---|---|
| When does the final rule become effective? | July 20, 2026 |
| Who is covered? | Agents, brokers, and web-brokers assisting with enrollment through Federally-facilitated Exchanges and State-based Exchanges on the Federal platform |
| Are all zero-dollar premium claims prohibited? | No. The rule prohibits false claims or suggestions that consumers will always qualify |
| Are enrollment incentives restricted? | Yes. Cash, rebates, gift cards, travel vouchers, and cash equivalents cannot be used to induce enrollment |
| Are organizations responsible for vendor advertising? | They can be responsible when the vendor is contracted, directed, or compensated to market on their behalf |
| Will CMS approve advertisements before publication? | No |
| Can HHS request marketing materials? | Yes, for monitoring, audit, or enforcement |
| Is there a new 10-year retention rule for marketing? | No, although maintaining an internal archive remains a sensible control |
Key Takeaways
- →The 2027 ACA marketing rules become effective July 20, 2026 and codify seven non-exhaustive prohibited practices for agents, brokers, and web-brokers.
- →Organizations can be held responsible for marketing produced by contracted, directed, or compensated third parties including lead generators, affiliates, and call centers.
- →CMS does not pre-approve advertisements. Internal review, version control, and live monitoring are the organization's responsibility.
- →The HHS standardized consumer consent form is not required until enrollments for plan years beginning January 1, 2028 -- a separate timeline from the July 20 marketing standards.
- →The fix requires shared visibility, clear ownership, controlled language, version history, live monitoring, and a reliable correction process.
Why does July 20, 2026 matter for ACA marketers?
The rule turns several recurring marketing problems into expressly identified prohibited practices.
Marketing teams could previously rely on a broader standard requiring correct information and prohibiting misleading or coercive conduct. The 2027 final rule gives agents, brokers, web-brokers, vendors, and compliance teams a more specific list of practices that can trigger scrutiny.
This changes the operating expectation.
A compliance policy stored in a shared drive is insufficient when affiliates, agencies, publishers, call centers, and independent agents can change consumer-facing language after approval. Organizations need visibility into what is running, who approved it, who changed it, and how quickly it can be corrected.
Who must follow the new ACA marketing requirements?
The federal standards apply to agents, brokers, and web-brokers assisting consumers with qualified health plan (QHP) enrollment through:
- Federally-facilitated Exchanges (FFEs)
- State-based Exchanges on the Federal platform (SBE-FPs)
The requirements do not directly apply to fully State-based Exchanges. Those states may choose to adopt similar standards and may already enforce their own insurance advertising, producer-licensing, privacy, and consumer-protection rules.
Organizations operating across several states should avoid assuming that compliance with the federal rule resolves every state requirement. Federal and state obligations should be mapped together before campaigns are approved.
What marketing practices does the rule prohibit?
The final rule codifies seven non-exhaustive examples of prohibited marketing practices.
1. Cash or cash-equivalent enrollment inducements
Agents, brokers, and web-brokers may not offer cash, monetary rebates, gift cards, travel vouchers, or other cash equivalents to induce a consumer to enroll.
2. Gifts that fail the rule's conditions
A gift must be of nominal value, offered to similarly situated consumers without regard to whether they enroll, and cannot take the form of cash or a cash equivalent. Applicable state requirements may impose additional restrictions.
3. False zero-dollar insurance or premium claims
Marketing may not falsely assert or suggest that consumers will always qualify for zero-dollar insurance or a zero-dollar premium. Eligibility depends on the consumer's circumstances, available plans, household information, location, and eligibility for financial assistance.
4. False government logos or official appearances
Advertisements may not use identical or imitation government logos, symbols, or notations in a way that causes consumers to believe a private website or advertisement is an official government resource.
5. Inaccurate enrollment timelines and deadlines
The rule prohibits false, inaccurate, or misleading information about enrollment periods and deadlines, including Special Enrollment Period (SEP) deadlines.
6. False descriptions of laws or government actions
Advertisements may not misstate legislation, regulations, or executive orders. This includes fictional citations, inaccurate references, and misleading descriptions of what a government action requires or provides.
7. False celebrity, political, or notable-person endorsements
Marketing may not falsely claim that a celebrity, politician, or other notable person endorsed an agent, broker, web-broker, or agency. Centers for Medicare and Medicaid Services specifically included artificial intelligence-generated videos, deepfakes, and falsely attributed quotations in its discussion of this prohibition.
The seven examples are not the full universe of potential violations. Marketing can still be considered noncompliant when it is misleading, materially inaccurate, coercive, or omits material information.
Are zero-dollar ACA premium advertisements now prohibited?
No. The rule does not prohibit every reference to a zero-dollar premium.
It prohibits falsely asserting or suggesting that consumers will always qualify.
An advertisement stating that everyone qualifies for free coverage presents a conditional outcome as a guarantee. It may also lead a consumer to disclose personally identifiable information based on an inaccurate expectation.
Centers for Medicare and Medicaid Services explained that misleading zero-dollar advertising can expose consumers to unauthorized enrollment or other unauthorized uses of their information.
This is an illustrative example. It is not CMS-approved language and should be reviewed against the campaign, product, audience, state requirements, and supporting evidence.
A zero-dollar monthly premium also does not mean the consumer will have no healthcare costs. Deductibles, copayments, coinsurance, network restrictions, and noncovered services may still apply.
How do the rules affect deadline and urgency language?
Urgency has long been used to improve marketing response rates. The compliance problem begins when the urgency is false or disconnected from the consumer's actual circumstances.
Examples requiring review include:
- "Enrollment closes tonight" when no applicable deadline has been established
- Countdown clocks that restart when the user returns
- Claims that a consumer is about to lose eligibility without verifying the facts
- Special Enrollment Period language that omits qualifying conditions
- Advertisements that continue displaying an expired date
- Call scripts that pressure consumers to enroll immediately when more time is available
Centers for Medicare and Medicaid Services stated that inaccurate deadline information can cause consumers to enroll prematurely in a plan they might not otherwise have selected. Enrollment dates should come from one controlled source and flow consistently into paid media, landing pages, email, text messaging, call scripts, comparison tools, and partner materials.
Who is responsible for marketing created by vendors and affiliates?
Agents, brokers, and web-brokers can be responsible for marketing produced on their behalf.
Centers for Medicare and Medicaid Services clarified that this responsibility applies when a third party is contracted, directed, or compensated by the agent, broker, or web-broker. The final rule encourages careful review of third-party marketing organizations, field marketing organizations, lead generators, and other downstream parties.
That may include:
- Lead-generation companies
- Affiliate publishers
- Marketing agencies
- Call-center vendors
- Field marketing organizations
- Third-party marketing organizations
- Independent contractors
- Subcontractors used by a primary vendor
A contract stating that a vendor must follow applicable laws does not confirm that the live advertisement is accurate.
Organizations need to know which vendors are representing them, what claims those vendors are using, where the advertisements are running, and whether subcontractors are involved. This is closely connected to the compliance-centered growth work VHealth focuses on across regulated healthcare and insurance distribution.
Will CMS approve ACA advertisements before publication?
No.
Centers for Medicare and Medicaid Services stated that it does not plan to review advertisements before publication or maintain a general repository of approved advertisements. The agent, broker, web-broker, or agency remains responsible for its review and approval process.
This places more weight on internal controls. Compliance teams need a repeatable method for reviewing claims before launch. Marketing and distribution teams need controls that prevent unapproved changes after launch.
Can HHS request copies of marketing materials?
Yes.
Agents, brokers, and web-brokers covered by the rule must produce marketing materials when requested by the Department of Health and Human Services for monitoring, audit, or enforcement.
Centers for Medicare and Medicaid Services did not establish a new 10-year retention requirement specifically for marketing materials. CMS explained that it actively reviews public advertising and frequently retains copies of the advertisements it investigates.
An internal archive is still a sound business control. It can help the organization show:
- Which version was approved
- What evidence supported the claim
- When the advertisement was active
- Which publishers distributed it
- Whether the live version matched the approved version
- When a correction or removal occurred
The absence of a federal 10-year requirement should not be interpreted as a reason to discard useful compliance evidence.
Does the July 20 rule require the new HHS consumer consent form?
No. The marketing standards and the standardized consent-form timeline should be treated separately.
The overall final rule becomes effective July 20, 2026. The required use of the HHS-approved and HHS-created consumer consent form was delayed until enrollments for plan years beginning on or after January 1, 2028. It will therefore affect the open enrollment period beginning in the fall of 2027, rather than the fall 2026 enrollment period.
Agents, brokers, and web-brokers still have existing consumer-consent and eligibility-application review obligations. The delayed date concerns the mandatory use of the standardized HHS form. This distinction should appear in training and implementation materials so teams do not combine two different effective dates.
What should organizations do before July 20, 2026?
1. Build an inventory of live marketing
Document every consumer-facing channel, including paid search, social media, video, display, email, text messaging, direct mail, comparison tools, landing pages, lead forms, call scripts, and partner websites. Assign an accountable owner to each asset.
2. Audit the highest-risk claims
Prioritize language involving free coverage, zero-dollar premiums, subsidies and savings, enrollment deadlines, Special Enrollment Periods, government relationships, gifts and incentives, celebrity or political endorsements, and eligibility guarantees. Confirm that every claim has supporting evidence and appropriate qualification.
3. Map the downstream marketing chain
Identify every agency, publisher, affiliate, lead generator, call center, and subcontractor involved in producing or distributing marketing. Contracts should establish approval rights, monitoring requirements, correction timelines, subcontractor disclosure, and access to campaign evidence.
4. Establish one source for dates and approved claims
Maintain a controlled claim library containing approved language, prohibited language, required qualifications, supporting sources, applicable states and products, approval dates, expiration dates, and assigned approvers. This reduces copy drift across marketing, sales, compliance, and partner teams.
5. Monitor what consumers actually see
Prepublication review confirms what was approved. It does not confirm what remained live. Teams should test advertisements and landing pages from different traffic sources, devices, states, and partner websites. Call recordings and transcripts should be sampled against approved scripts. Human-controlled artificial intelligence can help identify phrases such as "everyone qualifies," "free insurance," "deadline today," or unsupported government references across a large volume of materials. A qualified human reviewer should determine whether the language is compliant in context.
6. Create a documented correction process
The organization should be able to identify the owner of a questionable advertisement, pause distribution, preserve evidence, correct the asset, notify affected partners, and document completion. Measure how long this process takes. A policy that requires several days to locate the responsible publisher provides limited protection during a live campaign.
Why do these marketing controls matter to consumers?
A misleading advertisement can create problems long after the consumer clicks.
A consumer may provide personal information under a false assumption, rush into an enrollment decision, misunderstand the source of an advertisement, or discover that the premium, benefits, deadline, or eligibility rules differ from what was presented.
Those failures can lead to:
- Coverage confusion
- Unauthorized enrollment concerns
- Billing questions
- Plan changes
- Increased call-center volume
- Provider eligibility disputes
- Tax consequences involving incorrectly applied premium assistance
- Loss of trust in agents, insurers, and the Marketplace
Centers for Medicare and Medicaid Services stated that the updated standards are intended to reduce confusion, support informed decisions, and reduce situations in which misleading zero-dollar claims contribute to an incorrect application of advance payments of the premium tax credit.
What does this mean for healthcare marketing operations?
The July 20 deadline exposes a familiar operating problem: the organization cannot control what it cannot see.
Marketing may approve the original asset. An agency changes the headline. An affiliate adds urgency. A call center adjusts its script. Compliance discovers the change after a complaint.
The fix requires shared visibility, clear ownership, controlled language, version history, live monitoring, and a reliable correction process.
This is closely connected to the work VHealth focuses on across regulated healthcare operations. Fragmented information and weak handoffs allow small control failures to spread. Better visibility and disciplined workflows help organizations detect problems earlier, protect revenue, reduce audit exposure, and preserve consumer trust. See how VHealth approaches compliance-centered growth and data and workflow visibility for regulated organizations.
Frequently Asked Questions
When do the 2027 ACA marketing rules take effect?
The 2027 Notice of Benefit and Payment Parameters becomes effective July 20, 2026.
What ACA marketing claims are prohibited?
The rule identifies prohibited practices involving enrollment inducements, certain gifts, false zero-dollar claims, false government logos, inaccurate enrollment deadlines, misrepresentations of laws or government actions, and false endorsements. The list is non-exhaustive.
Can an ACA advertisement say that a consumer may qualify for a zero-dollar premium?
A carefully qualified statement may be permissible when it is accurate. The rule prohibits false assertions or suggestions that consumers will always qualify. Organizations should have legal and compliance reviewers approve specific language.
Can agents give gifts to prospective ACA enrollees?
Only under the conditions described in the rule. Gifts must be nominal, non-cash, offered to similarly situated consumers, and provided without regard to whether the consumer enrolls. State rules may also apply.
Are agents responsible for marketing produced by lead generators?
They can be responsible when the lead generator or other third party was contracted, directed, or compensated to produce marketing on their behalf.
Does CMS approve ACA advertisements before they run?
No. CMS does not plan to conduct general prepublication review or create a repository of approved advertisements.
Do the federal marketing rules apply to every State-based Exchange?
No. The standards apply to Federally-facilitated Exchanges and State-based Exchanges on the Federal platform. A fully State-based Exchange may choose to adopt similar requirements.
Is the HHS standardized consumer consent form required in 2026?
No. Mandatory use of the standardized form begins with enrollments for plan years starting on or after January 1, 2028. Existing consent and application-review requirements remain in effect.
What records should ACA marketers maintain?
The rule requires covered parties to provide marketing materials to HHS upon request, but CMS did not establish a new 10-year marketing retention period. Organizations should maintain enough evidence to document approvals, claims, distribution, live versions, corrections, and partner accountability.
A practical July 20 readiness test
Before July 20, leadership should be able to answer six questions:
Which ACA advertisements and scripts are currently live?
Who approved every material claim?
What evidence supports each claim?
Which vendors and downstream publishers are using the material?
How quickly can an inaccurate version be located and removed?
Can the organization produce the asset and its approval history when requested?
Any unanswered question identifies a control gap that should have an owner, a deadline, and a documented correction plan.
Sources
Related VHealth resources
Compliance-Centered Growth
Building compliant marketing and enrollment workflows in regulated healthcare
Data and Workflow Visibility
Connecting fragmented data into a governed, actionable operating layer
Advisory for Brokers and Agencies
Compliance-centered growth for insurance brokers, agencies, and distribution organizations
Performance Marketing Governance
How performance marketing should be governed in regulated healthcare markets
Editorial and legal note
This article is provided for general educational and operational-planning purposes. It does not constitute legal advice. Organizations should review the final rule, relevant CMS guidance, applicable state requirements, and their specific marketing practices with qualified legal and compliance professionals.
Get new VHealth insights in your inbox
Operations, compliance, AI implementation. No noise.